ArticleFrontiers in nutrition2026
Body composition in stable COPD: associations with disease severity and early sarcopenia prediction.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate body composition changes in patients with stable chronic obstructive pulmonary disease (COPD) and their correlation with disease severity, and to assess the value of body composition indices for early identification of concomitant sarcopenia. Methods: Patients with stable COPD were stratified according to the comprehensive disease severity assessment method in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, changes in body mass index (BMI), skeletal muscle index (SMI), body fat mass index (BFMI), and fat-free mass index (FFMI) were observed across groups. Factors associated with concomitant sarcopenia in COPD were analyzed, and Receiver Operating Characteristic (ROC) curves were plotted to evaluate the predictive value of the body composition indices for early screening of concomitant sarcopenia in patients with stable COPD. Results: A total of 237 patients with stable COPD (including 40 with concomitant sarcopenia) and 270 healthy controls were enrolled. In the stable COPD group, BMI, SMI, and FFMI were all positively correlated with FEV₁%pred and FEV₁/FVC (all Conclusion: Body composition alterations occur during the stable phase of COPD, especially a reduction in skeletal muscle mass. Changes in skeletal muscle indices in patients with stable COPD are significantly correlated with disease severity. Body composition analysis has potential clinical value for early identification of skeletal muscle impairment and disease assessment in stable COPD patients, and may be considered as a supplementary component of routine follow-up.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.